MoneyWorks4Me

RPG Life Sciences - Quaterly Results

25 Jan 2022 Evaluate
The revenue zoomed 7.42% to Rs. 1155.80 millions for the quarter ended December 2021 as compared to Rs. 1076.00 millions during the corresponding quarter last year.Profit saw a slight increase of 13.68%to Rs. 146.30  millions from Rs. 128.70 millions.The company reported a good operating profit of 247.10 millions compared to 214.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 1155.80 1076.00 7.42 3363.60 2963.80 13.49 3891.40 3755.70 3.61
Other Income 6.10 1.20 408.33 17.30 6.10 183.61 9.10 7.30 24.66
PBIDT 247.10 214.20 15.36 745.80 578.80 28.85 708.40 598.80 18.30
Interest 1.60 1.60 0.00 4.60 7.00 -34.29 7.90 17.50 -54.86
PBDT 245.50 212.60 15.48 741.20 571.80 29.63 700.50 528.10 32.65
Depreciation 39.30 41.90 -6.21 118.80 125.50 -5.34 164.70 163.60 0.67
PBT 206.20 170.70 20.80 622.40 446.30 39.46 535.80 364.50 47.00
TAX 59.90 42.00 42.62 182.80 115.50 58.27 135.80 74.40 82.53
Deferred Tax -1.90 -11.60 -83.62 -3.80 -26.50 -85.66 -35.70 -26.60 34.21
PAT 146.30 128.70 13.68 439.60 330.80 32.89 400.00 290.10 37.88
Equity 132.30 132.30 0.00 132.30 132.30 0.00 132.30 132.30 0.00
PBIDTM(%) 21.38 19.91 7.39 22.17 19.53 13.54 18.20 15.94 14.18
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..